Ori Gutwerg

All filings by Ori Gutwerg on record concern ANI Pharmaceuticals Inc. We count 37 filings; the first trade dates from 15 February 2021 and the latest from 10 August 2026.

Sales make up the whole of the open-market record (9 sales, €2.2M). Outside the open market, there are 26 share grants and 2 option exercises. So far in 2026, the count stands at no purchases and 2 sales.

Most recently, on 11 August 2026, the filings show an open-market sale worth €211k in ANI Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.